Freenome

Freenome: Series D Funding Round

Freenome has successfully raised $290M in Series D funding, reaching a valuation of $1.1B.

Company Overview

AI-driven early cancer detection

Funding Details

The Series D round was led by Perceptive Advisors, with participation from RA Capital Management, Andreessen Horowitz, GV, T. Rowe Price, Roche Venture Fund.

Company Information

• Headquarters: 279 East Grand Avenue, South San Francisco, CA 94080
• Founded: 2014
• Employees: 400+
• Category: Biotech

Investment

Freenome plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

• Perceptive Advisors: Verified investor in Series D
• RA Capital Management: Verified investor in Series D
• Andreessen Horowitz: Verified investor in Series D
• GV: Verified investor in Series D
• T. Rowe Price: Verified investor in Series D
• Roche Venture Fund: Verified investor in Series D